The consumer healthcare company has appointed a leading New Zealand distributor to represent its brands in the local market, supporting its strategy to increase awareness and distribution of its products in additional regional markets.
The retailer announces the resignation of a non-executive director to focus on other business interests.
This consumer healthcare business reported a 40.4% revenue increase to $23.6 million, but saw losses widen. The company settled key liabilities and expects strong growth, yet faces ongoing profitability challenges.
The consumer healthcare company has announced the resignation of its Joint CEO, with the remaining CEO to assume sole leadership.
The consumer healthcare company has divested a minor brand to focus on its key product lines.
The consumer healthcare company has issued new ordinary shares to settle fees related to its AIM admission.
The consumer healthcare business reported a 46% increase in revenue for the first four months of 2025, with April sales up 75% year-over-year. The company also extinguished debt and achieved cost savings from its recent AIM listing.
The consumer healthcare company announces changes to its board and management team, including the resignation of the Non-Executive Chairman and the appointment of an interim replacement.